ANTIPLATELET GPIIB/IIIA (7E3) ANTIBODY IN ELECTIVE PTCA - SAFETY AND INHIBITION OF PLATELET-FUNCTION

被引：0
|
作者：
ELLIS, SG [1 ]
NAVETTA, FI [1 ]
TCHENG, JT [1 ]
WEISMAN, HF [1 ]
WANG, AL [1 ]
PITT, B [1 ]
TOPOL, EJ [1 ]
机构：
[1] UNIV MICHIGAN,ANN ARBOR,MI 48109
来源：
CIRCULATION | 1990年 / 82卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [41] COMPARATIVE EFFECTS ON PLATELET-AGGREGATION IN REAL-TIME UNDER FLOWING CONDITIONS OF IN-VIVO ASPIRIN, HEPARIN AND MONOCLONAL-ANTIBODY 7E3 AGAINST GLYCOPROTEIN-IIB-IIIA
    TURNER, NA
    MOAKE, JL
    KUMAT, S
    MCINTIRE, LV
    BLOOD, 1993, 82 (10) : A282 - A282
  • [42] A DRAMATIC REDUCTION OF THE IMMUNOGENICITY OF THE ANTI-GPIIB/IIIA MONOCLONAL-ANTIBODY, 7E3-FAB, BY HUMANIZATION OF THE MURINE CONSTANT DOMAINS
    JORDAN, RE
    KNIGHT, DM
    WAGNER, C
    MCALEER, MF
    MCDONOUGH, M
    MATTIS, JA
    COLLER, BS
    WEISMAN, HF
    GHRAYEB, J
    CIRCULATION, 1992, 86 (04) : 411 - 411
  • [43] Discovery of novel orally active non-peptide antiplatelet GPIIb/IIIa antagonist, DMP754: Comparative platelet binding affinity profiles with DMP728 and c7E3
    Mousa, SA
    Bozarth, J
    Forsythe, M
    Xue, CB
    Wityak, J
    Olson, R
    Thoolen, M
    Reilly, T
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2707 - P2707
  • [44] Successful reperfusion in acute myocardial infarction by single bolus injection of the GPIIb/IIIa-receptor antibody c7E3 (abciximab)
    Domanovits, H
    Nikfardjam, M
    Gamper, G
    Schreiber, W
    Janata, K
    GottsaunerWolf, M
    Laggner, AN
    Huber, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2721 - P2721
  • [45] Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosis
    Makkar, RR
    Litvack, F
    Eigler, NL
    Nakamura, M
    Ivey, PA
    Forrester, JS
    Shah, PK
    Jordan, RE
    Kaul, S
    CIRCULATION, 1997, 95 (04) : 1015 - 1021
  • [46] Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody - Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and ''clinical restenosis''
    Reverter, JC
    Beguin, S
    Kessels, H
    Kumar, R
    Hemker, HC
    Coller, BS
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03): : 863 - 874
  • [47] Platelet GPIIb/IIIa binding characteristics of c7E3 (ReoPro) versus small molecule RGD mimetics (DMP728 and Roxifiban)
    Bozarth, JM
    Jordan, RE
    Mousa, SA
    FASEB JOURNAL, 1999, 13 (05): : A837 - A837
  • [48] Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA)
    Zahn, R
    Haubelt, H
    Bechtloff, S
    Schneider, S
    Frilling, B
    Rustige, J
    Marsalek, P
    Seidl, K
    Senges, J
    Hellstern, P
    HERZ, 2003, 28 (05) : 445 - 452
  • [49] Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: Insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial
    Marmur, Jonathan D.
    Mitre, Cristina A.
    Barnathan, Elliot
    Cavusoglu, Erdal
    AMERICAN HEART JOURNAL, 2006, 152 (05) : 876 - 881
  • [50] Platelet GPIIb/IIIa receptor blockade by 7E3 F(ab')(2) protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli.
    Taylor, FB
    Esmon, CT
    Chang, ACK
    Peer, G
    Jordan, R
    Engellenner, W
    Coller, BS
    BLOOD, 1996, 88 (10) : 1861 - 1861
12345